FDA
-
-
-
-
-
-
-
DELFI Diagnostics Study on Cancer Treatment Monitoring Using Fragmentomes Featured in Nature Communications
-
-
-
-
-
-
-
Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Medison Pharma Announces Expansion of the Multi-Territorial Agreement with Immunocore into Latin America
-
-
-
-
-
-
-
Immunocore announces dosing of first patient with ImmTAV® bispecific for HIV
-
-
-
-
-
-
-
The UK Medicines and Healthcare products Regulatory Agency (MHRA), Australian Therapeutic Goods Administration (TGA) and Health Canada approve KIMMTRAK® (tebentafusp) for the treatment of unresectabl
-
-
-
-
-
-
-
Immunocore to present at upcoming investor conferences
-
-
-
-
-
-
-
Acacia Research Reports First Quarter 2022 Financial Results
-
335,055 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


